This website is currently being merged into the Sydney Children's Hospitals Network website. As such, the content on this site is not guaranteed to be correct. Please visit our new website for the most up to date content. Thank you.
Public Health Alerts Emergency Information
You are here: Home

Media Releases

Thursday, 22 February 2001

Joshua Holland Leukaemia Fund Reaches Goals

On Thursday, 22nd February 2001, the Sydney Children's Hospital Foundation (SCHF) - Joshua Holland Leukaemia Fund will commemorate its first anniversary of establishment and announce achievements of the Fund over the past year.

Kate Holland established the SCHF - Joshua Holland Leukaemia Fund in memory of her son Joshua who lost his brave battle against a rare type of Leukaemia, just two days before Christmas 1999.
Joshua was only 22 months old and his family has vowed to keep his spirit alive by helping other children and their families who are still fighting a similar battle.

The Fund, launched on what would have been Joshua's 2nd birthday in February 2000, was set up primarily to help raise funds to improve facilities in the cancer ward and for clinical research for cancer patients treated at the Sydney Children's Hospital, Randwick.

Over the past year, thanks to the generosity of sponsors, supporters and committee members including: AAP Information Services, Vergola NSW, Retravision, Sandlyn Wilderness Estate, IEM Pty Ltd and All Protection Tinting Pty Ltd, the SCHF - Joshua Holland Leukaemia Fund has been successful in $140,000 to benefit children fighting cancer.

'Although many of the original goals have been reached, we are still striving to gain more financial support to provide ongoing funding for clinical research,' said Kate Holland.

The Sydney Children's Hospital, Randwick is an internationally recognised centre of excellence for child health with a full range of specialist services treating children from all over NSW and Australia.

For Further Information Contact:

Holly Bradshaw, Foundation Media Liaison Manager Tel: 9382 1188 Mob: 0414 821 187

Back to Media Release Listing